Shares in pharmaceutical giant Eli Lilly (LLY) gained 8% after the firm raised its 2026 profit guidance. That took its market cap to $968 billion, making it the next company in contention for a $1 trillion valuation. Share price: $1,080 (+8%) PE: 48x Market cap: $968bn Yield: 0.55% WEIGHT-LOSS DRUGS LEAD Eli Lilly raised its … Continue reading Eli Lilly shares gain on raised guidance